12 May 2020 - Deborah Wilkes
Archived
Sweden’s Karo Pharma has acquired the remaining European rights to the Pevaryl antifungal brand portfolio from Johnson & Johnson (J&J) for EUR58 million (USD63 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.